BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6150007)

  • 1. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.
    Brennan MJ; Cisar JO; Vatter AE; Sandberg AL
    Infect Immun; 1984 Nov; 46(2):459-64. PubMed ID: 6150008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinomyces adsorption mediated by type-1 fimbriae.
    Clark WB; Wheeler TT; Lane MD; Cisar JO
    J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes.
    Sandberg AL; Mudrick LL; Cisar JO; Brennan MJ; Mergenhagen SE; Vatter AE
    Infect Immun; 1986 Nov; 54(2):472-6. PubMed ID: 2876961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and function of Actinomyces naeslundii T14V type 1 fimbriae require the expression of additional fimbria-associated genes.
    Yeung MK; Ragsdale PA
    Infect Immun; 1997 Jul; 65(7):2629-39. PubMed ID: 9199430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and immunological comparison of surface fibrils of strains representing six taxonomic groups of Actinomyces viscosus and Actinomyces naeslundii.
    Masuda N; Ellen RP; Fillery ED; Grove DA
    Infect Immun; 1983 Mar; 39(3):1325-33. PubMed ID: 6188696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):73s-79s. PubMed ID: 6108369
    [No Abstract]   [Full Text] [Related]  

  • 14. Actinomyces viscosus fibril antigens detected by immunogold electron microscopy.
    Ellen RP; Buivids IA; Simardone JR
    Infect Immun; 1989 Apr; 57(4):1327-31. PubMed ID: 2564376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
    Clark WB; Wheeler TT; Cisar JO
    Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 95 kDa putative adhesin from Actinomyces serovar WVA963 strain PK1259 that is distinct from type 2 fimbrial subunits.
    Klier CM; Kolenbrander PE; Roble AG; Marco ML; Cross S; Handley PS
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():835-846. PubMed ID: 9084167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii.
    Cisar JO; Sandberg AL; Mergenhagen SE
    J Dent Res; 1984 Mar; 63(3):393-6. PubMed ID: 6142065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.
    Haber J; Grinnell CM; Beem JE; Clark WB
    Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.